MARTINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 2.630
AS - Asia 2.043
EU - Europa 1.214
SA - Sud America 317
AF - Africa 304
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 16
Totale 6.551
Nazione #
US - Stati Uniti d'America 2.455
SG - Singapore 575
VN - Vietnam 462
IT - Italia 339
CN - Cina 291
HK - Hong Kong 243
BR - Brasile 200
ES - Italia 172
DE - Germania 74
FR - Francia 74
IN - India 68
FI - Finlandia 66
RU - Federazione Russa 55
NL - Olanda 54
GB - Regno Unito 53
PL - Polonia 51
BD - Bangladesh 49
TR - Turchia 34
MX - Messico 32
SE - Svezia 30
AR - Argentina 29
JP - Giappone 28
PH - Filippine 27
CA - Canada 26
IQ - Iraq 25
AT - Austria 24
ZA - Sudafrica 23
ID - Indonesia 20
CZ - Repubblica Ceca 19
UA - Ucraina 19
EC - Ecuador 18
IE - Irlanda 16
KR - Corea 16
BJ - Benin 13
CY - Cipro 13
AL - Albania 12
CR - Costa Rica 12
JO - Giordania 12
MA - Marocco 12
PK - Pakistan 12
SA - Arabia Saudita 12
TZ - Tanzania 12
UZ - Uzbekistan 12
VE - Venezuela 12
BE - Belgio 11
CH - Svizzera 11
CI - Costa d'Avorio 11
CO - Colombia 11
EG - Egitto 11
KE - Kenya 11
NE - Niger 11
RE - Reunion 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
BO - Bolivia 10
CL - Cile 10
CU - Cuba 10
IL - Israele 10
JM - Giamaica 10
MY - Malesia 10
RW - Ruanda 10
YT - Mayotte 10
AO - Angola 9
ET - Etiopia 9
KZ - Kazakistan 9
LY - Libia 9
PY - Paraguay 9
RO - Romania 9
SN - Senegal 9
TW - Taiwan 9
AM - Armenia 8
BA - Bosnia-Erzegovina 8
BB - Barbados 8
DK - Danimarca 8
EE - Estonia 8
HU - Ungheria 8
LC - Santa Lucia 8
ME - Montenegro 8
MG - Madagascar 8
MK - Macedonia 8
NO - Norvegia 8
RS - Serbia 8
TH - Thailandia 8
AU - Australia 7
BY - Bielorussia 7
CG - Congo 7
CW - ???statistics.table.value.countryCode.CW??? 7
GF - Guiana Francese 7
HN - Honduras 7
IR - Iran 7
KH - Cambogia 7
LV - Lettonia 7
MN - Mongolia 7
NP - Nepal 7
PA - Panama 7
PR - Porto Rico 7
PT - Portogallo 7
XK - ???statistics.table.value.countryCode.XK??? 7
ZW - Zimbabwe 7
BW - Botswana 6
Totale 6.284
Città #
San Jose 403
Ashburn 386
Singapore 336
Hong Kong 222
Fairfield 190
Ho Chi Minh City 142
Hanoi 131
Woodbridge 130
Sabadell 116
Chandler 103
Los Angeles 98
Cambridge 67
Houston 67
Seattle 61
Santa Clara 53
Wilmington 51
Ann Arbor 49
New York 41
Boardman 39
Padova 37
Beijing 36
Matadepera 34
Munich 33
Lauterbourg 31
Milan 31
Helsinki 29
Bytom 28
San Diego 28
Chicago 27
Council Bluffs 27
Da Nang 27
Orem 25
São Paulo 24
Rome 23
Guangzhou 19
Turku 19
Dong Ket 18
Medford 17
Princeton 17
Buffalo 16
Naples 16
Tokyo 16
Brooklyn 15
Johannesburg 15
Baghdad 14
Haiphong 14
Hefei 14
London 14
Phoenix 14
Cotonou 13
Des Moines 13
Montreal 13
Shanghai 13
Dublin 12
Nuremberg 12
Abidjan 11
Amsterdam 11
Padua 11
Redondo Beach 11
Amman 10
Dallas 10
Frankfurt am Main 10
Havana 10
Kigali 10
Kyiv 10
Mexico City 10
Niamey 10
Rio de Janeiro 10
Tashkent 10
Ankara 9
Dakar 9
Hyderabad 9
Istanbul 9
Nha Trang 9
Seoul 9
Stockholm 9
Villafranca Padovana 9
Vũng Tàu 9
Warsaw 9
Addis Ababa 8
Antananarivo 8
Bialystok 8
Castries 8
Dearborn 8
Lappeenranta 8
Manchester 8
Podgorica 8
Roxbury 8
Atlanta 7
Boston 7
Bridgetown 7
Dar es Salaam 7
Denver 7
Hangzhou 7
Harare 7
Jacksonville 7
Kingston 7
Lahore 7
Limassol 7
Mamoudzou 7
Totale 3.829
Nome #
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study 414
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 341
Tocilizumab for severe COVID-19 pneumonia 317
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 273
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 271
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma 259
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 256
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 233
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer 230
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 224
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 223
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 218
Occult liver disease burden: Analysis from a large general practitioners’ database 213
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 213
Natural history of acute kidney disease in patients with cirrhosis 199
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 192
SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS 191
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 186
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C 178
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 165
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases 158
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies 157
Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients 156
Liver pro-oncogenic potential of SERPINB3. 140
SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives 138
SERPINB3 INCREASES RESISTANCE TO CISPLATIN-INDUCED CELL DEATH IN HEPATOMA CELLS THROUGH INHIBITION OF THE PERMEABILITY TRANSITON PORE 125
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma 120
Human epididymis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies 106
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 105
Predictors of Persistent Disease Activity and Damage in Systemic Sclerosis: Associations With Mortality in a Single-Center Cohort Study 88
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab 87
The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma 83
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 82
Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma 70
Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma 62
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 59
The Role of PAR2 in MASLD Progression and HCC Development 57
Outcome of hepatic resection for HCC in ideal and non-ideal candidates 26
Totale 6.615
Categoria #
all - tutte 16.781
article - articoli 16.229
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 552
Totale 33.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 13 43
2021/2022278 29 49 12 12 17 24 23 12 10 17 19 54
2022/2023196 38 22 8 20 29 22 1 16 27 2 8 3
2023/2024200 3 22 23 20 17 19 20 12 9 14 15 26
2024/2025939 12 70 52 53 69 26 64 61 74 51 151 256
2025/20264.358 238 249 462 591 526 219 858 331 451 248 185 0
Totale 6.615